We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+13.64%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$31B
AUM Growth
+$2.56B
Cap. Flow
-$251M
Cap. Flow %
-0.81%
Top 10 Hldgs %
24.28%
Holding
1,159
New
101
Increased
405
Reduced
447
Closed
97

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$74.5M
2
HPQ icon
HP
HPQ
+$45.4M
3
CMCSA icon
Comcast
CMCSA
+$36.6M
4
ETN icon
Eaton
ETN
+$32.7M
5
OMC icon
Omnicom Group
OMC
+$31.9M

Top Sells

Rank Stock Value
1
AXP icon
American Express
AXP
+$76.1M
2
UPS icon
United Parcel Service
UPS
+$69.8M
3
CAT icon
Caterpillar
CAT
+$65.2M
4
LLY icon
Eli Lilly
LLY
+$64.7M
5
PAYX icon
Paychex
PAYX
+$39.7M

Sector Composition

Rank Sector Weight
1 Technology 34.6%
2 Healthcare 18.07%
3 Consumer Discretionary 12.63%
4 Financials 8.01%
5 Industrials 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RHI icon
301
Robert Half
RHI
$4.11B
$16.6M 0.05%
188,347
-48,432
-20% -$3.85M
FNV icon
302
Franco-Nevada
FNV
$41.3B
$16.5M 0.05%
148,602
-7,076
-5% -$861K
MSI icon
303
Motorola Solutions
MSI
$72.1B
$16.4M 0.05%
52,460
+2,605
+5% +$788K
ARGX icon
304
argenx
ARGX
$55.2B
$16.4M 0.05%
43,073
-1,228
-3% -$572K
WPM icon
305
Wheaton Precious Metals
WPM
$49.7B
$16.3M 0.05%
331,295
-25,888
-7% -$1.17M
SPY icon
306
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$16.3M 0.05%
34,266
TAP icon
307
Molson Coors Class B
TAP
$8.02B
$16.2M 0.05%
265,290
+93,775
+55% +$5.64M
RARE icon
308
Ultragenyx Pharmaceutical
RARE
$2.46B
$15.9M 0.05%
332,712
-11,787
-3% -$457K
HEI icon
309
HEICO Corp
HEI
$49.6B
$15.8M 0.05%
88,238
-1,673
-2% -$283K
EG icon
310
Everest Group
EG
$15.6B
$15.6M 0.05%
44,256
+42,117
+1,969% +$16.3M
GLOB icon
311
Globant
GLOB
$1.65B
$15.6M 0.05%
65,417
-66,184
-50% -$13.5M
INFY icon
312
Infosys
INFY
$51B
$15.4M 0.05%
836,630
-56,152
-6% -$977K
EXPE icon
313
Expedia Group
EXPE
$36.5B
$15.4M 0.05%
101,178
+98,918
+4,377% +$12.1M
ICLR icon
314
Icon
ICLR
$13.7B
$15.3M 0.05%
54,193
-6,513
-11% -$1.69M
NBIX icon
315
Neurocrine Biosciences
NBIX
$18.2B
$15.3M 0.05%
116,211
-2,718
-2% -$313K
DOC
316
DELISTED
PHYSICIANS REALTY TRUST
DOC
$15.2M 0.05%
1,143,301
-193,790
-14% -$2.3M
ADI icon
317
Analog Devices
ADI
$172B
$15.2M 0.05%
76,620
+3,182
+4% +$568K
KRNT icon
318
Kornit Digital
KRNT
$677M
$15.1M 0.05%
789,061
-292,921
-27% -$5.08M
ROK icon
319
Rockwell Automation
ROK
$51.1B
$15M 0.05%
48,223
+36,702
+319% +$10.3M
CRUS icon
320
Cirrus Logic
CRUS
$6.76B
$14.8M 0.05%
177,703
-1,343
-0.8% -$101K
SPOT icon
321
Spotify
SPOT
$108B
$14.7M 0.05%
78,437
-3,240
-4% -$566K
DOV icon
322
Dover
DOV
$26.7B
$14.7M 0.05%
95,695
-35,566
-27% -$4.98M
IT icon
323
Gartner
IT
$11.1B
$14.6M 0.05%
32,367
+22,364
+224% +$8.93M
MEDP icon
324
Medpace
MEDP
$16.3B
$14.6M 0.05%
47,591
+11,091
+30% +$2.99M
OTIS icon
325
Otis Worldwide
OTIS
$27.9B
$14.5M 0.05%
162,443
-12,552
-7% -$1.04M

Similar funds

Axa's Q4 2023 Portfolio in Review

As of Q4 2023, Axa held 1,159 positions worth $31B, up 9% from $28.5B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Axa's Q4 2023 filing shows 101 new, 405 increased, 447 reduced and 97 closed positions. Its largest new stake was Nucor: 169,957 shares worth $29.6M. The largest sale was American Express, an estimated $76.1M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q4 2023 buy was Nucor: 169,957 shares worth $29.6M.
  • Axa added most to NVIDIA in Q4 2023, an estimated $74.5M increase.
  • Axa's biggest Q4 2023 reduction was American Express, cutting an estimated $76.1M.
  • Axa fully exited Activision Blizzard in Q4 2023, selling an estimated $24.6M.
  • Axa's ten largest holdings make up 24% of its $31B portfolio in Q4 2023.
  • Axa opened 101 new positions and closed 97 in Q4 2023.
  • Axa's portfolio value rose 9% quarter-over-quarter to $31B.

Based on Axa's 13F filing for Q4 2023, filed 14 Feb 2024.